Yang Xianghua 4

4 · iQIYI, Inc. · Filed May 13, 2026

AI-generated summary of this filing

Updated May 13, 2026

iQIYI SVP Yang Xianghua Receives Option Awards (Amendment)

What Happened

Yang Xianghua, Senior Vice President of iQIYI (IQ), was party to derivative transactions on 2026-05-11 that show two simultaneous dispositions to the issuer and matching grants: 4,812,117 shares and 5,600,000 shares (total 10,412,117). Each disposition (D) to the issuer is paired with an acquisition/grant (A) for the same number of derivative shares. No dollar prices or cash amounts are reported (N/A), indicating these were non‑market option/award transactions rather than open‑market buys or sells.
The filing and accompanying footnotes indicate these transactions reflect amendments to outstanding options (effectively canceling prior options and issuing new ones) that extend option expiration dates (amended expirations noted as 10/18/2030 for affected grants).

Key Details

Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (appears timely).
Reported movements: Disposition of 4,812,117 derivative shares and regrant of 4,812,117; disposition of 5,600,000 and regrant of 5,600,000 (total 10,412,117).
Price/value: N/A in the filing (no cash proceeds or open‑market prices reported).
Shares owned after transaction: Not specified in the provided filing details.
Notable footnotes: Filing explains vesting/terms differ by tranche — some grants vest 25% after one year then quarterly thereafter, some vest 25% each anniversary, and some previously vested tranches were fully vested. Two footnotes note that the amendments may be treated as cancellation of original options (expiring earlier) and grant of new options with expiration extended to 10/18/2030.
Transaction type: Derivative amendment/regrant (not a typical buy or sale). Codes used: D = Disposition to issuer (cancellation), A = Grant/award (new options).

Context

For retail investors: these transactions are adjustments to option awards and extend the life of the options; they do not represent open‑market purchases or sales of common stock and therefore shouldn't be read as a straightforward bullish or bearish trade. Because some tranches were already vested and others have multi‑year vesting schedules, the economic benefit and timing for Yang depend on vesting and any future exercises or sales.

Form 4

Period: 2026-05-11

Senior Vice President

Transactions

Disposition to Issuer
Option (right to buy)
[F4][F3]
2026-05-11−4,812,117→ 0 total
Exercise: $0.51Exp: 2027-02-14→ Class A ordinary share (4,812,117 underlying)
Award
Option (right to buy)
[F4][F3]
2026-05-11+4,812,117→ 4,812,117 total
Exercise: $0.51Exp: 2030-10-18→ Class A ordinary share (4,812,117 underlying)
Disposition to Issuer
Option (right to buy)
[F6][F5]
2026-05-11−5,600,000→ 0 total
Exercise: $0.51Exp: 2028-02-28→ Class A ordinary share (5,600,000 underlying)
Award
Option (right to buy)
[F6][F5]
2026-05-11+5,600,000→ 5,600,000 total
Exercise: $0.51Exp: 2030-10-18→ Class A ordinary share (5,600,000 underlying)

Holdings

Option (right to buy)
[F1]
Exercise: $0.51Exp: 2036-05-11→ Class A ordinary share (2,275,000 underlying)
2,275,000
Option (right to buy)
[F2]
Exercise: $0.00Exp: 2036-05-11→ Class A ordinary share (2,450,000 underlying)
2,450,000

Footnotes (6)

[F1]The options vest over a four-year period, with 25% vesting on the 1st anniversary of 05/11/2026, and the remaining 75% vesting in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F2]The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.
[F3]The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F4]The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.
[F5]The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
[F6]The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

Signature

/s/ Yang Xianghua|2026-05-13

1 file